TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Brief Summary: The Symplicity HTN-3 study is a, multi-center, prospective, single-blind, randomized, controlled study of the safety and effectiveness of renal denervation in subjects with uncontrolled hypertension. Bilateral renal denervation will be performed using the Symplicity Catheter - a percutaneous system that delivers radiofrequency (RF)energy through the luminal surface of the renal artery.


Options:
A: Arm Label: renal sympathetic denervation; Type: EXPERIMENTAL; Interventions: Procedure: renal sympathetic denervation, Drug: drug, Procedure: Direct-Current Cardioversion | Arm Label: drug therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: drug | Intervention Type: PROCEDURE; Name: renal sympathetic denervation; Assigned to Arm(s): renal sympathetic denervation | Intervention Type: DRUG; Name: drug; Assigned to Arm(s): drug therapy, renal sympathetic denervation | Intervention Type: PROCEDURE; Name: Direct-Current Cardioversion; Assigned to Arm(s): renal sympathetic denervation
B: Intervention Type: DEVICE; Name: Symplicty(TM) Catheter System; Assigned to Arm(s): N/A
C: Arm Label: Renal Denervation; Type: EXPERIMENTAL; Interventions: Device: Symplicity Spyral™ multi-electrode renal denervation system | Arm Label: Sham Procedure; Type: SHAM_COMPARATOR; Interventions: Procedure: Sham Procedure | Intervention Type: DEVICE; Name: Symplicity Spyral™ multi-electrode renal denervation system; Assigned to Arm(s): Renal Denervation | Intervention Type: PROCEDURE; Name: Sham Procedure; Assigned to Arm(s): Sham Procedure
D: Arm Label: Renal Denervation; Type: EXPERIMENTAL; Interventions: Device: Renal denervation (Symplicity Catheter System), Diagnostic Test: Renal angiogram | Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Diagnostic Test: Renal angiogram | Intervention Type: DEVICE; Name: Renal denervation (Symplicity Catheter System); Assigned to Arm(s): Renal Denervation | Intervention Type: DIAGNOSTIC_TEST; Name: Renal angiogram; Assigned to Arm(s): Control group, Renal Denervation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Brief Summary: The Symplicity HTN-3 study is a, multi-center, prospective, single-blind, randomized, controlled study of the safety and effectiveness of renal denervation in subjects with uncontrolled hypertension. Bilateral renal denervation will be performed using the Symplicity Catheter - a percutaneous system that delivers radiofrequency (RF)energy through the luminal surface of the renal artery.


Options:
A: Arm Label: Renal Denervation; Type: EXPERIMENTAL; Interventions: Device: Renal denervation (Symplicity Catheter System), Diagnostic Test: Renal angiogram | Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Diagnostic Test: Renal angiogram | Intervention Type: DEVICE; Name: Renal denervation (Symplicity Catheter System); Assigned to Arm(s): Renal Denervation | Intervention Type: DIAGNOSTIC_TEST; Name: Renal angiogram; Assigned to Arm(s): Control group, Renal Denervation
B: Arm Label: PV isolation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Circumferential PV isolation | Arm Label: PV isolation+renal denervation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: PV isolation+renal denervation | Intervention Type: PROCEDURE; Name: Circumferential PV isolation; Assigned to Arm(s): PV isolation | Intervention Type: PROCEDURE; Name: PV isolation+renal denervation; Assigned to Arm(s): PV isolation+renal denervation
C: Arm Label: Renal Denervation; Type: EXPERIMENTAL; Interventions: Device: Renal denervation with a catheter-based procedure (Symplicity® Catheter System) | Arm Label: Maintenance of Medications; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Renal denervation with a catheter-based procedure (Symplicity® Catheter System); Assigned to Arm(s): Renal Denervation
D: Arm Label: Renal sympathetic denervation; Type: EXPERIMENTAL; Interventions: Device: Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA) | Arm Label: Sham procedure; Type: SHAM_COMPARATOR; Interventions: Other: Sham procedure | Intervention Type: DEVICE; Name: Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA); Assigned to Arm(s): Renal sympathetic denervation | Intervention Type: OTHER; Name: Sham procedure; Assigned to Arm(s): Sham procedure

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Low Protein Diet Supplemented Keto-/Amino Acid in Preventing the Progression of Chronic Kidney Disease(CKD)- ELPD Study
Brief Summary: The purpose of this study is to determine whether low protein diet and very low protein diet supplemented keto-/amino acid is effective in preventing the progression of chronic kidney disease (CKD , stage 3b and 4).


Options:
A: Intervention Type: BEHAVIORAL; Name: low protein diet; Assigned to Arm(s): N/A
B: Arm Label: Keto-diet (KD); Type: EXPERIMENTAL; Interventions: Dietary Supplement: Very low protein diet supplemented with Ketosteril | Arm Label: Low Protein Diet group (LPD); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional low protein diet | Intervention Type: BEHAVIORAL; Name: Conventional low protein diet; Assigned to Arm(s): Low Protein Diet group (LPD) | Intervention Type: DIETARY_SUPPLEMENT; Name: Very low protein diet supplemented with Ketosteril; Assigned to Arm(s): Keto-diet (KD)
C: Arm Label: low protein diet; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: low protein diet plusα-keto acid; Type: EXPERIMENTAL; Interventions: Behavioral: low protein diet plus α-keto acid | Arm Label: very low protein diet plus α-keto acid; Type: EXPERIMENTAL; Interventions: Behavioral: very low protein diet plus α-keto acid | Intervention Type: BEHAVIORAL; Name: low protein diet plus α-keto acid; Assigned to Arm(s): low protein diet plusα-keto acid | Intervention Type: BEHAVIORAL; Name: very low protein diet plus α-keto acid; Assigned to Arm(s): very low protein diet plus α-keto acid
D: Arm Label: VLPD diet; Type: EXPERIMENTAL; Interventions: Behavioral: Very low protein diet | Arm Label: LPD diet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low protein diet | Intervention Type: BEHAVIORAL; Name: Very low protein diet; Assigned to Arm(s): VLPD diet | Intervention Type: BEHAVIORAL; Name: Low protein diet; Assigned to Arm(s): LPD diet

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Adverse Pregnancy Outcome With Vitamin D Supplementation During Pregnancy
Brief Summary: We hypothesized that vitamin D supplementation during pregnancy can prevent adverse pregnancy outcome.


Options:
A: Arm Label: Study group; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: D Max drops | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: D Max drops; Assigned to Arm(s): Study group
B: Arm Label: Group A; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 | Arm Label: Group C; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 | Arm Label: Group D; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 | Arm Label: Group E; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): Group B, Group C, Group D, Group E | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Group A
C: Arm Label: Vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cholecalciferol D3 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo tablet | Intervention Type: DIETARY_SUPPLEMENT; Name: Cholecalciferol D3; Assigned to Arm(s): Vitamin D | Intervention Type: OTHER; Name: Placebo tablet; Assigned to Arm(s): Placebo
D: Arm Label: Prenatal Vitamin D3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Prenatal Vitamin | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Prenatal Vitamin, Drug: Cholecalciferol (Vitamin D3) | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Prenatal Vitamin, Drug: Cholecalciferol (Vitamin D3) | Intervention Type: DRUG; Name: Prenatal Vitamin; Assigned to Arm(s): 2, 3, Prenatal Vitamin D3 | Intervention Type: DRUG; Name: Cholecalciferol (Vitamin D3); Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Cholecalciferol (Vitamin D3); Assigned to Arm(s): 3

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Cluster-Randomized Clinical Trial Of Two Educational Strategies In Cardiovascular Health (CVH) In Child Population. The Savinghearts Project
Brief Summary: AIM: To evaluate the effectiveness of two strategies in cardiovascular risk in children 2º grade in the community of Madrid.

DESIGN: cluster-randomized trial with blinded evaluator SCOPE AND SUBJECTS OF STUDY: Children of both sexes enrolled in 2º grade in public schools in the community of Madrid. Rate exclusion criteria INTERVENTION: Schools were randomly assigned to two groups: an experimental group that the investigators organized a concert teaching focused on messages cardio, a second group or control group to which they will host a healthy breakfast as it has been offering the Community of Madrid .

MEASUREMENTS: The primary end result is the increase of correct answers on a standardized test to be administered before and after the activity.

Secondary outcomes will be, improving the same questionnaire at 6 months and reduced overall weight and center from before the intervention at 6 months of it.


Options:
A: Arm Label: Scouting curricular implementation; Type: EXPERIMENTAL; Interventions: Behavioral: Scouting Nutrition and Activity Program | Arm Label: Standard-care attentional control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard-care attentional control | Intervention Type: BEHAVIORAL; Name: Scouting Nutrition and Activity Program; Assigned to Arm(s): Scouting curricular implementation | Intervention Type: BEHAVIORAL; Name: Standard-care attentional control; Assigned to Arm(s): Standard-care attentional control
B: Arm Label: Lifestyle intervention; Type: OTHER; Interventions: Behavioral: Physical activity, dietary counseling, coaching | Intervention Type: BEHAVIORAL; Name: Physical activity, dietary counseling, coaching; Assigned to Arm(s): Lifestyle intervention
C: Arm Label: Healthy Breakfast; Type: ACTIVE_COMPARATOR; Interventions: Other: Didactic Concerts | Arm Label: Didactic concerts; Type: EXPERIMENTAL; Interventions: Other: Didactic Concerts | Intervention Type: OTHER; Name: Didactic Concerts; Assigned to Arm(s): Didactic concerts, Healthy Breakfast
D: Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle counseling | Intervention Type: BEHAVIORAL; Name: Lifestyle counseling; Assigned to Arm(s): Lifestyle counseling

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Brief Summary: The purpose of this study is to see if testosterone solution 2% can impact symptoms of ejaculatory dysfunction in men with low testosterone.


Options:
A: Arm Label: Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oral testosterone undecanoate (Andriol) | Arm Label: Arm 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Oral testosterone undecanoate (Andriol); Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm 2
B: Arm Label: Testosterone Solution 2% 60 milligrams (mg); Type: EXPERIMENTAL; Interventions: Drug: Testosterone Solution 2% | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Solution | Intervention Type: DRUG; Name: Testosterone Solution 2%; Assigned to Arm(s): Testosterone Solution 2% 60 milligrams (mg) | Intervention Type: DRUG; Name: Placebo Solution; Assigned to Arm(s): Placebo
C: Arm Label: Testim; Type: ACTIVE_COMPARATOR; Interventions: Drug: Testosterone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Testosterone; Assigned to Arm(s): Testim | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nebido (testosterone undecanoate) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Nebido (testosterone undecanoate); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: DO IT Trial: Vitamin D Outcomes and Interventions In Toddlers
Brief Summary: Vitamin D can be made in the skin by exposure to sunlight and can be found in certain foods. Vitamin D levels are alarmingly low in many North American children. Several health issues have been linked with low vitamin D. These include colds caused by viruses and asthma attacks. However, no study has determined whether vitamin D supplementation can reduce the risk of these conditions in young children where they are most common and most severe.

The goals of this study are to determine whether wintertime high dose vitamin D supplementation of preschoolers can prevent colds and asthma attacks. The investigators also aim to work out how much money would be saved by the health care system and society if preschoolers were routinely supplemented with Vitamin D during the winter. The investigators believe that preschoolers receiving 'high dose' vitamin D supplementation during the wintertime will be less likely to have colds, asthma attacks, and low vitamin D levels and will be less likely to use the medical system and keep their parents away from work.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: daily vitamin D supplement, Other: Placebo | Arm Label: Vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin D, Dietary Supplement: daily vitamin D supplement | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D; Assigned to Arm(s): Vitamin D | Intervention Type: DIETARY_SUPPLEMENT; Name: daily vitamin D supplement; Assigned to Arm(s): Placebo, Vitamin D | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: vitamin D3; Type: EXPERIMENTAL; Interventions: Drug: vitamin D3 4000 IU | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: vitamin D3 4000 IU; Assigned to Arm(s): vitamin D3 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
C: Arm Label: 2000 IU per day vitamin D; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D3 - Cholecalciferol 2000 IU | Arm Label: 400 IU per day vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vitamin D - Cholecalciferol 400 IU | Intervention Type: DRUG; Name: Vitamin D - Cholecalciferol 400 IU; Assigned to Arm(s): 400 IU per day vitamin D | Intervention Type: DRUG; Name: Vitamin D3 - Cholecalciferol 2000 IU; Assigned to Arm(s): 2000 IU per day vitamin D
D: Arm Label: Reuterin D3 drops; Type: ACTIVE_COMPARATOR; Interventions: Drug: Reuterin D3 drops | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Reuterin D3 drops; Assigned to Arm(s): Reuterin D3 drops | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: DO IT Trial: Vitamin D Outcomes and Interventions In Toddlers
Brief Summary: Vitamin D can be made in the skin by exposure to sunlight and can be found in certain foods. Vitamin D levels are alarmingly low in many North American children. Several health issues have been linked with low vitamin D. These include colds caused by viruses and asthma attacks. However, no study has determined whether vitamin D supplementation can reduce the risk of these conditions in young children where they are most common and most severe.

The goals of this study are to determine whether wintertime high dose vitamin D supplementation of preschoolers can prevent colds and asthma attacks. The investigators also aim to work out how much money would be saved by the health care system and society if preschoolers were routinely supplemented with Vitamin D during the winter. The investigators believe that preschoolers receiving 'high dose' vitamin D supplementation during the wintertime will be less likely to have colds, asthma attacks, and low vitamin D levels and will be less likely to use the medical system and keep their parents away from work.


Options:
A: Arm Label: Ciclesonide + placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Ciclesonide | Arm Label: Ciclesonide + Vitamin D; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D3, Drug: Ciclesonide | Intervention Type: DRUG; Name: Vitamin D3; Assigned to Arm(s): Ciclesonide + Vitamin D | Intervention Type: DRUG; Name: Ciclesonide; Assigned to Arm(s): Ciclesonide + Vitamin D, Ciclesonide + placebo
B: Arm Label: Vigantol oil; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cholecalciferol | Arm Label: Miglyol oil; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Miglyol oil | Intervention Type: DIETARY_SUPPLEMENT; Name: Cholecalciferol; Assigned to Arm(s): Vigantol oil | Intervention Type: DIETARY_SUPPLEMENT; Name: Miglyol oil; Assigned to Arm(s): Miglyol oil
C: Arm Label: 2000 IU per day vitamin D; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D3 - Cholecalciferol 2000 IU | Arm Label: 400 IU per day vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vitamin D - Cholecalciferol 400 IU | Intervention Type: DRUG; Name: Vitamin D - Cholecalciferol 400 IU; Assigned to Arm(s): 400 IU per day vitamin D | Intervention Type: DRUG; Name: Vitamin D3 - Cholecalciferol 2000 IU; Assigned to Arm(s): 2000 IU per day vitamin D
D: Arm Label: Vigantol oil; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cholecalciferol | Arm Label: Miglyol oil; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Miglyol oil | Intervention Type: DIETARY_SUPPLEMENT; Name: Cholecalciferol; Assigned to Arm(s): Vigantol oil | Intervention Type: DIETARY_SUPPLEMENT; Name: Miglyol oil; Assigned to Arm(s): Miglyol oil

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: DO IT Trial: Vitamin D Outcomes and Interventions In Toddlers
Brief Summary: Vitamin D can be made in the skin by exposure to sunlight and can be found in certain foods. Vitamin D levels are alarmingly low in many North American children. Several health issues have been linked with low vitamin D. These include colds caused by viruses and asthma attacks. However, no study has determined whether vitamin D supplementation can reduce the risk of these conditions in young children where they are most common and most severe.

The goals of this study are to determine whether wintertime high dose vitamin D supplementation of preschoolers can prevent colds and asthma attacks. The investigators also aim to work out how much money would be saved by the health care system and society if preschoolers were routinely supplemented with Vitamin D during the winter. The investigators believe that preschoolers receiving 'high dose' vitamin D supplementation during the wintertime will be less likely to have colds, asthma attacks, and low vitamin D levels and will be less likely to use the medical system and keep their parents away from work.


Options:
A: Arm Label: Vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 (cholecalciferol) | Arm Label: Placebo; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3 (cholecalciferol); Assigned to Arm(s): Vitamin D3
C: Arm Label: 2000 IU per day vitamin D; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D3 - Cholecalciferol 2000 IU | Arm Label: 400 IU per day vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vitamin D - Cholecalciferol 400 IU | Intervention Type: DRUG; Name: Vitamin D - Cholecalciferol 400 IU; Assigned to Arm(s): 400 IU per day vitamin D | Intervention Type: DRUG; Name: Vitamin D3 - Cholecalciferol 2000 IU; Assigned to Arm(s): 2000 IU per day vitamin D
D: Arm Label: Intervention group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cholecalciferol | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Cholecalciferol; Assigned to Arm(s): Intervention group | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol
Brief Summary: The purpose of this study is to determine if pretreatment with Estrogen can assist in the planning and programming of In Vitro Fertilization treatments.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Patients receiving short protocol IVF/ICSI-treatment. | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Long protocol | Intervention Type: DRUG; Name: Patients receiving short protocol IVF/ICSI-treatment.; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Long protocol; Assigned to Arm(s): 2
B: Arm Label: GnRH agonist; Type: EXPERIMENTAL; Interventions: Drug: Triptorelin | Arm Label: GnRH antagonist; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cetrorelix | Intervention Type: DRUG; Name: Triptorelin; Assigned to Arm(s): GnRH agonist | Intervention Type: DRUG; Name: Cetrorelix; Assigned to Arm(s): GnRH antagonist
C: Arm Label: Observational Cohort; Type: N/A; Interventions: Drug: ganirelix | Arm Label: Historical Controls; Type: N/A; Interventions: Drug: GnRH agonist | Intervention Type: DRUG; Name: ganirelix; Assigned to Arm(s): Observational Cohort | Intervention Type: DRUG; Name: GnRH agonist; Assigned to Arm(s): Historical Controls
D: Arm Label: Follicular Estrogen, Antagonist, IVF; Type: EXPERIMENTAL; Interventions: Drug: estradiol valerate | Arm Label: long IVF protocol; Type: ACTIVE_COMPARATOR; Interventions: Drug: estradiol valerate | Intervention Type: DRUG; Name: estradiol valerate; Assigned to Arm(s): Follicular Estrogen, Antagonist, IVF, long IVF protocol

Answer: D